Reliable, rapid lateral flow immunochromatographic assay for the qualitative detection of nucleocapsid antigen from SARS-CoV-2 present in nasal samples.

The CareStart COVID-19 Antigen provides results in just 10 minutes, making it highly suitable for quick action at the point-of-care. Anterior (shallow) nasal sampling collects from the front area of the nose and is therefore less invasive, reduces patient discomfort and simplifies the overall testing procedure.

Anterior nasal swab samples may be particularly useful for children and elderly people, especially when used for frequent testing. This simplified collection method also allows for the option for patients to self-collect under supervision, offering reduced physical contact and exposure and further protection for healthcare practitioners.

Features:

Results in 10 minutes.

Quick and convenient

Used with a shallow nasal swab

Internationally validated

Manufactured in the USA by Access Bio

Contents:

• 20 x test device (individually wrapped in a foil pouch)

• 20 x pre-prepared extraction vials with buffer solution and 1 x vial caps

• 20 x sterile anterior nasal swab

• Instructions for use and quick reference guide

• Positive and negative controls